Researcher.Life Logo

Journal of Gastrointestinal Oncology : Impact Factor & More

eISSN: 2219-679XpISSN: 2078-6891

Key Metrics

CiteScore
3.3
H-Index
51
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.86
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Gastrointestinal Oncology

Journal of Gastrointestinal Oncology Journal Specifications

Overview
Publisher AME PUBLISHING COMPANY
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Gastrointestinal Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Gastrointestinal Oncology

Defining the role of endoscopic resection for esophageal gastrointestinal stromal tumors
  • 1 Jun 2026
  • Journal of Gastrointestinal Oncology
Retraction: Interfering HMGB3 release from cancer-associated fibroblasts by miR-200b represses chemoresistance and epithelial-mesenchymal transition of gastric cancer cells
  • 28 Apr 2026
  • Journal of Gastrointestinal Oncology
The 12-node rule in irradiated rectal cancer: time for reappraisal?
  • 28 Apr 2026
  • Journal of Gastrointestinal Oncology
KRAS mutation subtypes refine prognostic stratification in colorectal cancer: a retrospective cohort study
  • 28 Apr 2026
  • Journal of Gastrointestinal Oncology
Muscling in on body surface area to reduce oxaliplatin-induced peripheral neuropathy in colon cancer
  • 28 Apr 2026
  • Journal of Gastrointestinal Oncology
Anlotinib plus penpulimab: a new contender in first-line therapy for unresectable hepatocellular carcinoma
  • 28 Apr 2026
  • Journal of Gastrointestinal Oncology
Defining the role of endoscopic resection for esophageal gastrointestinal stromal tumors
  • 1 Jun 2026
  • Journal of Gastrointestinal Oncology
Retraction: Interfering HMGB3 release from cancer-associated fibroblasts by miR-200b represses chemoresistance and epithelial-mesenchymal transition of gastric cancer cells
  • 28 Apr 2026
  • Journal of Gastrointestinal Oncology
The 12-node rule in irradiated rectal cancer: time for reappraisal?
  • 28 Apr 2026
  • Journal of Gastrointestinal Oncology
KRAS mutation subtypes refine prognostic stratification in colorectal cancer: a retrospective cohort study
  • 28 Apr 2026
  • Journal of Gastrointestinal Oncology
Muscling in on body surface area to reduce oxaliplatin-induced peripheral neuropathy in colon cancer
  • 28 Apr 2026
  • Journal of Gastrointestinal Oncology
Anlotinib plus penpulimab: a new contender in first-line therapy for unresectable hepatocellular carcinoma
  • 28 Apr 2026
  • Journal of Gastrointestinal Oncology

FAQs on Journal of Gastrointestinal Oncology